An urgent call for environmental accountability in nephrology clinical trials.

The article discusses the urgent need for environmental accountability in nephrology clinical trials. It highlights the significant carbon dioxide equivalent (CO2e) emissions associated with clinical trials and emphasizes the lack of studies assessing the environmental impact of these trials. The article suggests various strategies to mitigate the environmental effects, such as optimizing trial site locations, reducing unnecessary data and sample collection, favoring local lab work, and minimizing travel for patients and the trial team. It also explores the potential benefits of digitalization, artificial intelligence (AI), and machine learning in improving the sustainability of clinical trials. The article calls for collective efforts from the nephrology community, including researchers, pharmaceutical companies, and funding bodies, to prioritize sustainability in clinical trials. [Extracted from the article]